MDC Connects - Complex Medicines: Selection and Characterisation of the Lead

  • 14:00, 18 May 21 - 15:00, 18 May 21
  • Medicines Discovery Catapult, Macclesfield
  • Print page
The medicines industry is in a period of change. While small molecule therapeutics still make up 90% of approved medicines, patient expectations are driving the industry towards targeted, precision treatments, which require a shift towards stratified, complex medicines with more challenging discovery and development needs.

This webinar will look at assays, technologies and capabilities which can be employed to characterise the lead molecule.


- Developing the assay cascade for complex medicines - Tilly Bingham (Concept Life Sciences)
- CryoEM in characterisation and quality control of complex medicines - Rebecca Thompson (Astbury Biostructure Laboratory)
- Cellular internalisation and trafficking of complex medicines - James Szczerkowski, Postdoc Scientist - Advanced Microscopy (MDC)